Products for Research Use Only
RegisterLogin

Fremanezumab

CAT: 0931-T76680-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T76680-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
1655501-53-3
Target
CGRP Receptor
Related Pathways
GPCR/G Protein, Neuroscience
Purity
0.976
Bioactivity
Fremanezumab (TEV-48125) is a humanised monoclonal antibody targeting CGRP, capable of neutralising human (IC50=7.94 nM), mouse (IC50=19.6 nM) and rat CGRP, and is indicated for the prevention of migraine. Fremanezumab inhibits CGRP's vasodilatory effects in the basilar artery constriction segment and suppresses activation of A-δ and high-threshold (HT) neurons in the meningeal nociceptive system triggered by cortical spreading depression (CSD) in rats. In vitro, Fremanezumab counteracts CGRP's immunosuppressive effects on microglia and lymphocytes.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Alternative Products

CatalogName
abx831393-01Fremanezumab
GTR18337597-01Fremanezumab Antibody
DHC22402Research Grade Fremanezumab
E55B0735Fremanezumab (Reference antibody)
591873Fremanezumab (CALCA, CALCB)
048304CALCA/CGRP (fremanezumab) discontinued
KBI1341KRIBIOLISA™ Fremanezumab (AJOVY) ELISA
ICH5045-5mgFremanezumab Biosimilar - Research Grade
GTR18781412-01(Fremanezumab) Biosimilar Reference Antibody
A2791-01Fremanezumab (Anti-CALCA / CGRP)

Popular Products